SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Eva Perón

PatientEva Perón
Date of birth1994-05-07
IdentifiersMRN HR-ML025-SYN; SSN (made up) 000-25-7316
Document date2026-03-02
AuthorLucía Barragán, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Staging results and treatment decisions. [S]

History of Present Illness

Ms. Perón returns two weeks after the diagnosis, in Spanish, to hear her staging results with Dr. Barragán and Dr. Osei-Bonsu, with the interpreter. She came alone by choice. She has thought about the fertility options and does not want to delay treatment for egg freezing or have an operation to move her ovaries; she understands that she will not be able to carry a pregnancy and that early menopause is likely, and is at peace with that decision. She has told a close friend and one colleague, and will tell her family herself. Bleeding is light, the pelvic ache is 3 of 10 with acetaminophen, and she has more energy since starting iron. Radiation planning was done three days ago. [S]

ElementDetail
StagingPelvic MRI and PET-CT done; HIV and hepatitis C negative
Fertility decisionDeclined egg freezing and ovarian transposition; does not want treatment delayed
Who knowsA friend and a colleague; she will tell her family herself
SymptomsLight bleeding; pelvic ache 3 of 10; more energy
ScoresPHQ-9 8; GAD-7 7

Review of Systems

SystemResultFinding
ConstitutionalNegativeMore energy; no fever or weight loss
GenitourinaryPositiveLight bleeding; no urinary symptoms
MusculoskeletalNegativeNo back pain or leg swelling
PsychiatricPositiveAnxious about treatment but hopeful; no thoughts of self-harm

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth once daily, with vitamin C-rich food or juice, apart from tea and dairyOne tablet by mouth once dailyOral route2026-02-09 to 2026-08-17completedS
Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours when needed for pelvic pain, no more than 6 tablets a dayOne or two tablets every 6 hours when needed, no more than 6 a dayOral route2026-02-09activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-03-02Body height165cmS
2026-03-02Body weight52.5kgS
2026-03-02Body mass index (BMI) [Ratio]19.3kg/m2S
2026-03-02Systolic blood pressure110mm[Hg]S
2026-03-02Diastolic blood pressure68mm[Hg]S
2026-03-02Heart rate84/minS
2026-03-02Respiratory rate14/minS
2026-03-02Body temperature36.7CelS
2026-03-02Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-02Hemoglobin [Mass/volume] in Blood10.2g/dL11.6-15 g/dLLowS
2026-03-02MCV [Entitic mean volume] in Red Blood Cells by Automated count77fL80-100 fLLowS
2026-03-02Leukocytes [#/volume] in Blood by Automated count6.810*3/uL4-11 10*3/uLNormalS
2026-03-02Platelets [#/volume] in Blood by Automated count35210*3/uL150-400 10*3/uLNormalS
2026-03-02Pain severity - 0-10 verbal numeric rating [Score] - Reported3{score}S
2026-03-02Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
2026-03-02Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]7{score}S

Physical Exam

Vital signs recorded on 2026-03-02; see the Vital Signs section. [S]

SystemFinding
GeneralLess pale; pulse 84, blood pressure 110/68
AbdomenSoft; no mass
Lymph nodesNo inguinal or supraclavicular nodes
PsychiatricCalm and engaged; asks about the treatment schedule

Problems

ProblemClinical statusVerificationCodeProvenance
Bleeding after intercourse and between periods, with heavier periods, for about four months, with tiredness and a dull pelvic ache. Never had cervical screening. Speculum examination shows a friable, exophytic mass about 4 cm across on the cervix that bleeds on contact. Punch biopsy, HPV test and cytology taken; urgent gynecologic oncology consultation bookedresolvedconfirmed N93.8S — Synthetic presenting problem linked to her documented abnormal bleeding with anemia; superseded by the diagnosis at the consultation.
Iron deficiency anemia from chronic blood loss: hemoglobin 9.4 g/dL, mean cell volume 72 fL, ferritin 6 ng/mL, with tiredness and breathlessness on stairsactiveconfirmed D50.0S — Synthetic modern finding linked to her documented anemia from vaginal bleeding.
Invasive squamous cell carcinoma of the cervix, HPV 16 positive: an exophytic tumor about 4.5 cm across with clinical involvement of the left parametrium, not reaching the pelvic wall; pelvic MRI and PET-CT ordered for FIGO 2018 staging. Synthetic modern episode linked to her documented cervical canceractiveconfirmed C53.9S — Synthetic modern diagnosis made at the gynecologic oncology consultation.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
Self-managementDisclosure and information preferences: she is told first, in Spanish, as much as she wants to know; she decides who else is toldEvery visitCompleted todayStage and likely outcome explained in Spanish; she chose to come alone and has told those she wished to
ImagingPelvic MRIAt staging, for local extentUp to dateSix days ago: left parametrial invasion, no pelvic wall, upper vagina only, no hydronephrosis or nodes
ImagingFDG PET-CTAt staging; about three months after chemoradiationUp to dateFour days ago: cervix only; no nodal or distant uptake. Next about three months after treatment
LaboratoryHIV and hepatitis C testsAt diagnosisUp to dateHIV and hepatitis C negative
LaboratoryBlood count (hemoglobin, white cells, platelets)About one month after starting oral iron, then every three months for a year; weekly during chemoradiationCompleted todayHemoglobin 10.2 g/dL, mean cell volume 77 fL, white cells 6.8, platelets 352
LaboratoryKidney function (creatinine, eGFR) and magnesium for cisplatinBefore cisplatin, weekly during it, and afterUp to dateCreatinine 0.7 mg/dL two weeks ago; weekly during cisplatin
SurveyPelvic pain score and analgesic safety (no anti-inflammatory painkillers with cisplatin)Every visitCompleted today3 of 10 on acetaminophen; no anti-inflammatory painkillers
SurveyPHQ-9 and GAD-7At diagnosis, before treatment, at mid-treatment, at the end of treatment, and in follow-upCompleted todayPHQ-9 8 (item 9 scored 0), GAD-7 7
ReferralFertility and ovarian function counseling and her decisionBefore cancer treatment beginsCompleted todayShe declined egg freezing and ovarian transposition after counseling
ReferralOncology social worker and spiritual careAt diagnosis and through treatmentCompleted todaySocial worker weekly during treatment; help with a reduced work schedule

Goal progress:

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027); Revised FIGO staging for carcinoma of the cervix uteri (2018 (published 2019)); Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline (2017); Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update (2018); Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023); CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026)

Follow-up: Chemoradiation starts in one week, with weekly reviews by the oncology team. Review here two weeks after brachytherapy. Next scheduled visit 2026-05-18: review two weeks after completing chemoradiation and brachytherapy: side effects, menopause symptoms, and survivorship care. [S]